Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma

• Vinod Kumar ,

  * E-mail: koichima@ims.u-tokyo.ac.jp

  Affiliations Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan

  ⨯
• Paulisally Hau Yi Lo,

  Affiliation Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Hiromi Sawai,

  Affiliation Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Naoya Kato,

  Affiliation Unit of Disease Control Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Atsushi Takahashi,

  Affiliation Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan

  ⨯
• Zhenzhong Deng,

  Affiliation Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Yuji Urabe,

  Affiliation Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Hamdi Mbarek,

  Affiliation Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Katsushi Tokunaga,

  Affiliation Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Yasuhito Tanaka,

  Affiliation Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan

  ⨯
• Masaya Sugiyama,

  Affiliation The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan

  ⨯
• Masashi Mizokami,

  Affiliation The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan

  ⨯
• Ryosuke Muroyama,

  Affiliation Unit of Disease Control Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Ryosuke Tateishi,

  Affiliation Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Masao Omata,

  Affiliation Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Kazuhiko Koike,

  Affiliation Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Chizu Tanikawa,

  Affiliation Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Naoyuki Kamatani,

  Affiliation Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan

  ⨯
• Michiaki Kubo,

  Affiliation Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan

  ⨯
• Yusuke Nakamura,

  Affiliation Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
•  [ ... ],
• Koichi Matsuda

  Affiliation Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• [ view all ]
• [ view less ]